Noncanonical FZD2 Signaling Induces EMT and Tumor Progression

    Cancer Discovery
    |August 28, 2021
    PubMed

    Insights

    Frizzled 2 (FZD2) and WNT5A proteins promote cancer cell epithelial-mesenchymal transition (EMT) and metastasis. This occurs through a noncanonical pathway involving FYN and STAT3 signaling.

    Area of Science:

    • Molecular oncology
    • Cell signaling pathways
    • Cancer metastasis research

    Background:

    • Epithelial-mesenchymal transition (EMT) is crucial for cancer metastasis.
    • Noncanonical Wnt signaling pathways regulate various cellular processes, including EMT.

    Purpose of the Study:

    • To elucidate the molecular mechanisms by which FZD2 and WNT5A contribute to EMT and metastasis.
    • To identify key signaling molecules involved in this noncanonical pathway.

    Main Methods:

    • Investigated the roles of Frizzled 2 (FZD2) and WNT5A in cancer cell models.
    • Utilized molecular biology techniques to analyze the involvement of FYN and STAT3 signaling.

    Main Results:

    • FZD2 and WNT5A were found to activate a noncanonical pathway.
    • This pathway involves the kinases FYN and the transcription factor STAT3.
    • Activation of this pathway drives EMT and enhances metastatic potential.

    Conclusions:

    • FZD2 and WNT5A are key drivers of EMT and metastasis through a noncanonical FYN/STAT3 signaling axis.
    • Targeting this pathway may offer novel therapeutic strategies for inhibiting cancer spread.

    Related Concept Videos

    Non-Canonical Wnt Signaling Pathways01:41

    Non-Canonical Wnt Signaling Pathways

    Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
    7.7K
    Canonical Wnt Signaling Pathway02:54

    Canonical Wnt Signaling Pathway

    The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
    9.3K
    Cadherins in Tissue Organization01:19

    Cadherins in Tissue Organization

    The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
    Cell Sorting During Development
    Cell sorting plays an...
    3.3K
    Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

    Role Of Notch Signalling In Intestinal Stem Cell Renewal

    Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
    Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
    2.2K
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    6.7K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    4.0K